Search research articles
Contact Us
Filters
Showing results (131-140 of 164) with videos related to
Page
of 17
Sort By:
Genome Research
|
February 28, 2019
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin
Kun Sun, Peiyong Jiang, Suk Hang Cheng, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy
Landon L Chan, Vanessa T Y Yeung, Winnie M T Soo, et al.
Clinical Chemistry
|
August 29, 2024
Methylation-Associated Nucleosomal Patterns of Cell-Free DNA in Cancer Patients and Pregnant Women
Guanhua Zhu, Peiyong Jiang, Xingqian Li, et al.
Drug Safety
|
June 15, 2026
Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis
Wei Kang, Bowie P Y Lam, Rinko Tsz Lam Lau, et al.
Journal of Hepatology
|
August 1, 2024
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
George Lau, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2022
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Gontran Verset, Ivan Borbath, Mark Karwal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
The New England Journal of Medicine
|
August 10, 2017
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K C Allen Chan, John K S Woo, Ann King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Winnie Yeo, Hyun C Chung, Stephen L Chan, et al.
The Lancet. Oncology
|
November 27, 2025
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
Shukui Qin, Shanzhi Gu, Stephen L Chan, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 164) with videos related to
Sort By:
Page
of 17
Genome Research
|
February 28, 2019
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin
Kun Sun, Peiyong Jiang, Suk Hang Cheng, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy
Landon L Chan, Vanessa T Y Yeung, Winnie M T Soo, et al.
Clinical Chemistry
|
August 29, 2024
Methylation-Associated Nucleosomal Patterns of Cell-Free DNA in Cancer Patients and Pregnant Women
Guanhua Zhu, Peiyong Jiang, Xingqian Li, et al.
Drug Safety
|
June 15, 2026
Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis
Wei Kang, Bowie P Y Lam, Rinko Tsz Lam Lau, et al.
Journal of Hepatology
|
August 1, 2024
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
George Lau, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2022
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Gontran Verset, Ivan Borbath, Mark Karwal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
The New England Journal of Medicine
|
August 10, 2017
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K C Allen Chan, John K S Woo, Ann King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Winnie Yeo, Hyun C Chung, Stephen L Chan, et al.
The Lancet. Oncology
|
November 27, 2025
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
Shukui Qin, Shanzhi Gu, Stephen L Chan, et al.
Page
of 17